Mon.Jun 20, 2022

Uniqueness if pharma DTC

World of DTC Marketing

Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. In addition, the patient journey is different for each product category and audience. Some will lead to more online research, while others may not.

New hybrid machine learning forecasts lake ecosystem responses to climate change

Scienmag

Throughout the middle of the 20th century, phosphorus inputs from detergents and fertilizers degraded the water quality of Switzerland’s Lake Geneva, spurring officials to take action to remediate pollution in the 1970s.

96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lilly’s Verzenios gets NICE blessing for early-stage breast cancer

Pharma Phorum

Thousands more people with breast cancer in England look set to be eligible for routine treatment with Eli Lilly’s Verzenios, after new guidance from NICE backed use of the drug after surgery for early-stage tumours.

Melting Arctic ice could transform international shipping routes, study finds

Scienmag

PROVIDENCE, R.I. Brown University] — With climate change rapidly warming the world’s oceans, the future of the Arctic Ocean looks grim.

83

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Merck, Emergent, Affinivax and Ocugen Level Up in Vaccine Development

BioSpace

???????The week began with positive updates in the vaccine development space against various infectious diseases from Emergent, Merck, Affinivax and Ocugen

Nanoparticles control flow of light like road signs direct traffic

Scienmag

Physicists at The Australian National University (ANU) have developed tiny translucent slides capable of producing two very different images by manipulating the direction in which light travels through them.

More Trending

The greening ashore

Scienmag

A team led by evolutionary biologist Prof. Dr. Sven Gould of Heinrich Heine University Düsseldorf (HHU) has been studying the current state of research on the plant colonisation of land that occurred some 500 million years ago.

Rain Targets Normal p53 Expression with Possible Pan-Cancer Therapeutic

BioSpace

In the coming 12 months, Rain expects to have an interim readout for a Phase II study of its liposarcoma therapy, milademetan, and a pivotal readout for its Phase III trial of the same compound

Single brain scan can diagnose Alzheimer’s disease

Scienmag

The research uses machine learning technology to look at structural features within the brain, including in regions not previously associated with Alzheimer’s.

FDA, HHS Sued by Doctors Over Controversial Drug Ivermectin

BioSpace

Three physicians filed a lawsuit against the FDA alleging the organization acted outside its authority and with their ability to practice medicine by discouraging the use of ivermectin to treat COVID-19

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

A rare discovery of long-term memory in wild frog-eating bats

Scienmag

COLUMBUS, Ohio – Frog-eating bats trained by researchers to associate a phone ringtone with a tasty treat were able to remember what they learned for up to four years in the wild, new research has found.

How to Navigate a Career Change From Pharma to Biotech

BioSpace

If you’re considering a career change from pharma to biotech, you’ll be happy to hear that according to industry experts, the transition is more common than you might think

84

New membrane improves reversibility of zinc-air batteries

Scienmag

The long-standing challenges to the practical implementation of rechargeable zinc-air batteries (ZABs) are the electrochemical irreversibility of the Zn anode and degradation of the air cathodes in alkaline electrolyte, which eventually results in poor cycle life and low cell voltage.

83

Pharma industry slams WTO move on TRIPS waiver

BioPharma Reporter

Pharma industry organizations say they are deeply disappointed by the decision taken by World Trade Organization (WTO) at its ministerial conference, MC12, to endorse a TRIPS waiver for COVID-19 vaccines. Markets & Regulations

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Fifth of global food-related emissions due to transport: research

Scienmag

In 2007, ‘locavore’ – a person who only eats food grown or produced within a 100-mile (161km) radius – was the Oxford Word of the Year. Now, 15 years later, University of Sydney researchers urge it to trend once more.

Pfizer takes stake in French Lyme disease jab partner Valneva

Pharma Phorum

Pfizer has acquired an 8.1% stake in French vaccines developer Valneva at a cost of €90.5 million (around $95 million) and rejigged the terms of their alliance to develop a shot for Lyme disease.

Who benefits from brain training and why?

Scienmag

RIVERSIDE, Calif. — If you are skilled at playing puzzles on your smartphone or tablet, what does it say about how fast you learn new puzzles, or, more broadly, how well you can focus, say, in school or at work? Or, in the language of psychologists, does “near transfer” predict “far transfer”?

83

New collaboration to accelerate advancements in gene therapies for dementia

BioPharma Reporter

The Cell and Gene Therapy Catapult (CGT Catapult) and the UK Dementia Research Institute (UK DRI) have announced a collaboration to accelerate clinical development of adeno-associated virus (AAV) based gene therapies for dementia. Bio Developments

Vital cell machinery behind the human body’s incorporation of selenium seen for the first time

Scienmag

A Rutgers scientist is part of an international team that has determined the process for incorporating selenium – an essential trace mineral found in soil, water and some foods that increases antioxidant effects in the body – to 25 specialized proteins, a discovery that could help develop new therapies to treat a multitude of diseases […].

Blood vessel breakthrough is major step towards Alzheimer’s treatment

PharmaTimes

The discovery may lead to development of drugs that halt disease progression and stop memory loss

Drugs 82

What makes blood vessels grow?

Scienmag

Joint press release by the Max Delbrück Center for Molecular Medicine and the Berlin Institute of Health at Charité Credit: Michael Potente, MDC Joint press release by the Max Delbrück Center for Molecular Medicine and the Berlin Institute of Health at Charité Blood vessels run throughout the human body and ensure that our organs get […].

Europe looks to next wave of COVID with coordinated supply plan

BioPharma Reporter

Following the adoption of a critical list of COVID-19 vaccines and treatments, European Union member states and pharma companies will communicate to ensure sufficient supply to meet evolving demand. Markets & Regulations

New editor-in-chief for CMAJ Open

Scienmag

The CMAJ Group is pleased to announce a new Editor-in-Chief, Erin Russell, for CMAJ Open, Canada’s open-access online medical journal, starting June 20, 2022.

Amvuttra RNAi Therapeutic Wins FDA Approval for Rare Genetic Protein Disorder

XTalks

Alnylam Pharmaceuticals, a leading RNA interference (RNAi) therapeutics biopharmaceutical company, announced it received approval from the US Food and Drug Administration (FDA) for its RNAi therapeutic Amvuttra (vutrisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated (ATTR) amyloidosis in adults.

RNA 82

New model helps identify mutations that drive cancer

Scienmag

CAMBRIDGE, MA — Cancer cells can have thousands of mutations in their DNA. However, only a handful of those actually drive the progression of cancer; the rest are just along for the ride. Distinguishing these harmful driver mutations from the neutral passengers could help researchers identify better drug targets. To boost those efforts, an MIT-led […]. Latest News cancer drive helps identify model mutations

DNA 63

AstraZeneca and Ionis Look to Carve Out Slice of ATTR Market

BioSpace

AstraZeneca and Ionis reported that their NEURO-TTRansform Phase III trial in hereditary transthyretin-mediated amyloid polyneuropathy hit its co-primary endpoints

Study links lower area-level income and education with greater likelihood of advanced lung cancer diagnosis

Scienmag

Lung cancer is the leading cause of cancer-related deaths in the United States, and early detection and treatment are key to prolonging survival in patients. A recent study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, found that area-level education and income are associated with patients’ lung cancer stage […]. Latest News advanced arealevel cancer diagnosis Education greater income likelihood links lung study

63

PTC Ready to Take Another Shot at FDA Approval of DMD Drug

BioSpace

For years, PTC Therapeutics has attempted to win regulatory approval for its DMD drug, Translarna. Now, the company believes it has data that will support another filing for FDA approval

Science coverage of climate change can change minds – briefly

Scienmag

COLUMBUS, Ohio – Science reporting on climate change does lead Americans to adopt more accurate beliefs and support government action on the issue – but these gains are fragile, a new study suggests. Researchers found that these accurate beliefs fade quickly and can erode when people are exposed to coverage skeptical of climate change. […]. Latest News briefly change climate coverage minds Science

Retracted Studies Continue to Spur Funding for Cardiac Stem Cell Research

BioSpace

Despite the refutation of research articles by Piero Anversa, they continue to serve as a basis for funding requests from scientists who hope to prove that the heart can regenerate cardiac muscle

New model offers potential solutions for next-generation battery challenges

Scienmag

A new study by Stanford University researchers lights a path forward for building better, safer lithium-metal batteries. Close cousins of the rechargeable lithium-ion cells widely used in portable electronics and electric cars, lithium-metal batteries hold tremendous promise as next-generation energy storage devices. Compared to lithium-ion devices, lithium-metal batteries hold more energy, charge up faster, and […].

The Future of Managing Regulatory Intelligence

Pharmaceutical Commerce

IQVIA’s Jens-Olaf Vanggaard discusses the challenges of managing regulatory intelligence on a global scale.

52

New effective combination therapy for paediatric T-acute leukaemia

Scienmag

Acute lymphoblastic leukaemia (ALL) is the most common cancer affecting children. The T-ALL form of leukaemia that emerges from early T lineage cells has a poorer prognosis than B-lineage ALL. The prognosis for relapsed T-ALL is very poor and new therapies are sorely needed. A joint study by Tampere University’s Faculty of Medicine and Health […]. Latest News combination effective leukaemia paediatric Tacute therapy

IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate

BioTech 365

IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate BETHESDA, Md.–(BUSINESS –(BUSINESS WIRE)–#IGC–India Globalization Capital, Inc.